NYSE:AMRX

Amneal Pharmaceuticals SEC Filings & 10K Form

$5.44
+0.13 (+2.45 %)
(As of 05/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.14
$5.45
50-Day Range
$5.20
$7.38
52-Week Range
$3.45
$7.45
Volume1.40 million shs
Average Volume1.80 million shs
Market Capitalization$1.63 billion
P/E Ratio13.27
Dividend YieldN/A
Beta1.27

SEC Filings

Amneal Pharmaceuticals (NYSE:AMRX) SEC Filings

DateFilerForm TypeView
05/11/2021
1:56 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
1:55 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
1:54 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
1:10 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
1:10 PM
Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
1:09 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
1:08 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
1:07 PM
Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
1:07 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
1:06 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
1:06 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
5:17 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2021
7:02 AM
Amneal Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
04/05/2021
7:03 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2021
7:01 AM
Amneal Pharmaceuticals (Filer)
Form DEFA14A
03/24/2021
7:00 AM
Amneal Pharmaceuticals (Filer)
Form DEF 14A
03/03/2021
4:07 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
4:06 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
4:05 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
4:04 PM
Amneal Pharmaceuticals (Issuer)
Manzano Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
4:03 PM
Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
3:39 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
3:38 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
5:35 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2021
2:04 PM
Amneal Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
02/10/2021
9:30 AM
Amneal Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/03/2021
12:33 PM
Amneal Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/12/2021
5:15 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
3:12 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:11 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:07 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:05 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2020
5:13 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2020
3:16 PM
Amneal Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/06/2020
5:09 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2020
3:16 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2020
7:39 AM
Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
7:37 AM
Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
7:35 AM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
10:46 AM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
3:15 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
5:47 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2020
6:28 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
6:12 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
6:11 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
6:11 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
6:09 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
6:43 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2020
4:27 PM
Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
4:25 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
4:23 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
4:23 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
6:50 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
6:49 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
6:49 PM
Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
6:47 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
4:48 PM
Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
3:02 PM
Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
2:57 PM
Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2020
4:19 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2020
6:54 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
6:54 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2020
8:15 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2020
8:14 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2020
8:13 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:27 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:27 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:26 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
7:19 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
7:19 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
7:18 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
7:16 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
7:13 PM
Amneal Pharmaceuticals (Issuer)
Manzano Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
7:08 PM
Amneal Pharmaceuticals (Issuer)
Branning Todd P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
7:05 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
3:55 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2020
5:50 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2020
3:49 PM
Amneal Pharmaceuticals (Filer)
Form 8-K/A
02/14/2020
3:27 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2020
5:59 AM
Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
Form SC 13G/A
02/12/2020
10:01 AM
Amneal Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/12/2020
6:23 AM
Amneal Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
Form SC 13G/A
02/05/2020
10:26 AM
Amneal Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/28/2020
11:05 AM
Amneal Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/23/2020
4:42 PM
Amneal Pharmaceuticals (Issuer)
Branning Todd P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
9:32 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
5:08 PM
Amneal Pharmaceuticals (Issuer)
Manzano Stephen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/06/2020
4:20 PM
Amneal Pharmaceuticals (Issuer)
BUCHEN DAVID A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
4:44 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
4:44 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
4:43 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
4:52 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2019
4:51 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2019
4:51 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2019
3:50 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
3:51 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
1:18 PM
Amneal Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
11/14/2019
4:27 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
4:27 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
4:26 PM
Amneal Pharmaceuticals (Issuer)
Bhadauria Pradeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 5/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.